Skip to main content
. 2020 Apr 3;13(5):960–971. doi: 10.1111/cts.12783

Table 1.

Phenotypic diversity in COL1A1 a and COL1A2 b pathogenic variants discovered in patients with OI from the UT OI biobank

No. Pathogenic variant Gene Mutation type Collagen defect Protein alteration Sillence OI type reported in the UT OI database studied cohort c Sillence OI type reported in the Dalgleish OI variant database c
1. Monophenotypes
1.1 Mild monophenotypes
1 c.590G>A COL1A1 Missense DN p.Gly197Asp I (1) I (2)
2 c.3766G>A COL1A1 Missense DN p.Ala1256Thr I (1) I (1)
3 c.1354‐2A>G COL1A1 Splice site LOF I (1) I (1)
4 c.904‐9G>A COL1A1 Splice site LOF I (2) I (1)
5 c.579_delT COL1A1 Frameshift LOF p.Gly194Valfs*71 I (1) I (22)
6 c.459_delT COL1A1 Frameshift LOF p.Gly154Alafs*111 I (1) I (1)
7 c.3807G>A COL1A1 Nonsense LOF p.Trp1269* I (1) I (2)
8 c.3076C>T COL1A1 Nonsense LOF p.Arg1026* I (1) I (12)
1.2 Moderate monophenotype
1 c.1630G>A COL1A2 Missense DN p.Gly544Ser IV (1) IV (1)
1.3 Severe monophenotype
1 c.1165G>A COL1A1 Missense DN p.Gly389Ser III (1) III (3)
2 c.742G>A COL1A1 Missense DN p.Gly284Arg III (1) III (1)
2. Polyphenotypes
2.1 Less variable phenotypes
2.1.1 Mild‐to‐moderate OI phenotypes
1 c.2560G>A‡ COL1A1 Missense DN p.Gly854Ser I, IV (1) I/IV (2)
2 c.3235G>A COL1A1 Missense DN p.Gly1079Ser I (1) I, IV (20)
3 c.653G>A COL1A1 Missense DN p.Gly218Asp I (2) IV (1)
4 c.959G>A COL1A1 Missense DN p.Gly320Asp IV (1) I (1)
5 c.1451G>A COL1A2 Missense DN p.Gly484Glu IV (1) I (2)
6 c.3305G>T COL1A2 Missense DN p.Gly1102Val I (1) IV (1)
7 c.750+2T>A‡ COL1A1 Splice site LOF I, IV (1) I (1)
8 c.3045+1G>A COL1A1 Splice site LOF IV (1) I (1)
9 c.299‐1G>C‡ COL1A1 Splice site LOF IV (1) I (3)
10 c.1614+1G>A COL1A1 Splice site LOF IV (1) I (3)
11 c.858+1G>A‡ COL1A1 Splice site LOF I, IV (2) I (2)
12 c.804+1G>A COL1A1 Splice site LOF IV (1) I (1)
13 c.1002+2T>C COL1A1 Splice site LOF IV (1) I (1)
14 c.1299+1G>C COL1A1 Splice site LOF IV (1) I, IV (4)
15 c.2614‐1G>A COL1A1 Splice site LOF IV (1) I (1)
16 c.2523_delT COL1A1 Frameshift LOF p.Gly842Alafs*266 I (1) I, IV (4)
17 c.658C>T‡ COL1A1 Nonsense LOF p.Arg220* I, IV (1) I (11)
18 c.2089C>T COL1A1 Nonsense LOF p.Arg697* IV (1) I, IV (8)
19 c.1789G>T COL1A1 Nonsense LOF p.Glu597* I (1) IV (1)
20 c.1081C>T COL1A1 Nonsense LOF p.Arg361* IV (2) I (10)
2.1.2 Severe‐to‐moderate phenotypes
1 c.2101G>T COL1A1 Missense DN p.Gly701Cys III (1) IV (1)
2 c.3226G>A COL1A1 Missense DN p.Gly1076Ser IV (2) III, IV (13)
3 c.1090G>A COL1A2 Missense DN p.Gly364Ser III (1) IV (1)
4 c.2288G>T COL1A2 Missense DN p.Gly763Val III (1) III/IV (2)
5 c.2324G>A COL1A2 Missense DN p.Gly775Glu III (2) III, IV (1)
6 c.3034G>A COL1A2 Missense DN p.Gly1012Ser III (2) III/IV (24)
7 c.865G>A COL1A2 Missense DN p.Gly289Ser III (1) III/IV, IV (2)
8 c.792+1G>A COL1A2 Splice site LOF III (1) IV (1)
9 c.2613+6T>C COL1A1 Splice site LOF IV (1) III (1)
2.2 More variable phenotypes
2.2.1 Opposite OI phenotypes
1 c.1072G>T‡ COL1A2 Missense DN p.Gly358Ser I, III (1) III (1)
2 c.2233G>C COL1A2 Missense DN p.Gly745Arg III (1) I (1)
3 c.874G>A COL1A2 Missense DN p.Gly292Ser III (1) I (5)
2.2.2 Non‐lethal phenotypes
1 c.2362G>A COL1A1 Missense DN p.Gly788Ser IV (2) I, III, IV (8)
2 c.2461G>A‡ COL1A1 Missense DN p.Gly821Ser I, IV (5) I, III, IV (26)
3 c.757C>T COL1A1 Missense DN p.Arg253Phe IV (1) I, III, IV (11)
4 c.769G>A‡ COL1A1 Missense DN p.Gly257Arg I, IV (1) I, III, IV (37)
5 c.977G>A COL1A1 Missense DN p.Gly326Asp I (1) I, III, IV (3)
6 c.1057G>T‡ COL1A1 Missense DN p.Gly353Cys I, IV (1) III/IV (2)
7 c.1165G>T COL1A1 Missense DN p.Gly389Cys I (2) III/ IV (2)
8 c.2314G>A‡ COL1A2 Missense DN p.Gly772Ser I, IV (1) I, III, IV (18)
9 c.2503G>A COL1A2 Missense DN p.Gly835Ser III (1) I, III, IV (4)
10 c.982G>A‡ COL1A2 Missense DN p.Gly328Ser IV, III (2) I, III, IV (45)
11 c.1009G>A COL1A2 Missense DN p.Gly337Ser III, IV (3) I, III, IV (29)
12 c.1821+1G>A‡ COL1A1 Splice site LOF III, IV, I (2) I, IV (17)
13 c.1243C>T COL1A1 Nonsense LOF p.Arg415* I (1) I, III/IV (16)
14 c.1128_delT‡ COL1A1 Frameshift LOF p.Gly377Alafs*164 I, IV, III (1) I (9)
2.2.3 Mild‐to‐lethal phenotypes
1 c.1102G>A COL1A1 Missense DN p.Gly368Ser IV (1) II/III, III (2)
2 c.1588G>A COL1A1 Missense DN p.Gly530Ser III (1) II, III, IV (12)
3 c.2299G>A COL1A1 Missense DN p.Gly767Ser I, III, IV (3) I, II, III, IV (34)
4 c.2596G>A COL1A1 Missense DN p.Gly866Ser III (1) II, III (10)
5 c.1378G>A COL1A2 Missense DN p.Gly460Ser IV (1) II/III, III, IV (16)

OI types reported in the OI variant database were obtained from http://www.le.ac.uk/ge/collagen/.

DN, dominant negative; LOF, loss‐of‐function; OI, osteogenesis imperfecta; UT, University of Tartu.

a

COL1A1 GenBank reference sequence (gDNA NG_007400.1, cDNA NM_000088.3). b COL1A2 GenBank reference sequence (gDNA NG_007405.1, cDNA NM_000089.3). cThe number of reported families in the UT OI database and the number of reported cases in the Dalgleish variant database are represented in parentheses.

*

“Stop codon” in mutation nomenclature.

Variants which caused variety of phenotypes intrafamilially are marked with a diesis (‡).